Order Article Reprints

D’Andrea D, Capone V, Bellis A, Castaldo R, Franzese M, Carpinella G, Furbatto F, La Rocca F, Marsico F, Marfella R, et al. PCSK9 Inhibitors “Fast Track” Use Versus “Stepwise” Lipid-Lowering Therapy in Patients with Acute Coronary Syndrome: A Retrospective Single-Center Study in a “Real-World” Population. Journal of Clinical Medicine. 2025; 14(9):2992. https://doi.org/10.3390/jcm14092992

D’Andrea, Davide, Valentina Capone, Alessandro Bellis, Rossana Castaldo, Monica Franzese, Gerardo Carpinella, Fulvio Furbatto, Fulvio La Rocca, Fabio Marsico, Raffaele Marfella, and et al. 2025. "PCSK9 Inhibitors “Fast Track” Use Versus “Stepwise” Lipid-Lowering Therapy in Patients with Acute Coronary Syndrome: A Retrospective Single-Center Study in a “Real-World” Population" Journal of Clinical Medicine 14, no. 9: 2992. https://doi.org/10.3390/jcm14092992

D’Andrea, D., Capone, V., Bellis, A., Castaldo, R., Franzese, M., Carpinella, G., Furbatto, F., La Rocca, F., Marsico, F., Marfella, R., Paolisso, G., Paolisso, P., Fumagalli, C., Cappiello, M., Bossone, E., & Mauro, C. (2025). PCSK9 Inhibitors “Fast Track” Use Versus “Stepwise” Lipid-Lowering Therapy in Patients with Acute Coronary Syndrome: A Retrospective Single-Center Study in a “Real-World” Population. Journal of Clinical Medicine, 14(9), 2992. https://doi.org/10.3390/jcm14092992